Gotenba, Japan

Hiroshi Araya


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hiroshi Araya

Hiroshi Araya is a notable inventor based in Gotenba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on quinolinone derivatives. His research and inventions have the potential to impact the medical industry positively.

Latest Patents

Hiroshi Araya holds a patent for a quinolinone derivative pharmaceutical composition and its production method. This composition comprises a quinolinone derivative represented by a specific structural formula. The particles of this derivative have an average diameter ranging from 0.5 to 10 micrometers, with 90% or more of the particles measuring 15 micrometers or less. Additionally, these particles exhibit a fusion enthalpy of 30 J/g or more. The surface of the particles is coated with a water-soluble composition containing a water-soluble polymer, which allows for quick dissolution of the active ingredient in the digestive tract and enhances long-term storage stability. This patent showcases his innovative approach to pharmaceutical formulations.

Career Highlights

Hiroshi Araya is associated with Dainippon Ink and Chemicals, Incorporated, where he has been able to apply his expertise in developing pharmaceutical compositions. His work has contributed to advancements in drug formulation and delivery systems.

Collaborations

Hiroshi has collaborated with notable colleagues, including Ryuji Kubota and Kouki Obata. These collaborations have likely fostered a creative environment that encourages innovation and the development of new ideas in the pharmaceutical field.

Conclusion

Hiroshi Araya's contributions to the pharmaceutical industry through his innovative patent on quinolinone derivatives highlight his role as a significant inventor. His work not only demonstrates his expertise but also has the potential to improve drug formulations and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…